+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Infection Market by Treatment (Antibiotics, Non Antibiotic Therapies), Age Group (Adults, Geriatrics, Pediatrics), Gender, End User - Global Forecast 2025-2030- Product Image
Urinary Tract Infection Market by Treatment (Antibiotics, Non Antibiotic Therapies), Age Group (Adults, Geriatrics, Pediatrics), Gender, End User - Global Forecast 2025-2030- Product Image
Sale

Urinary Tract Infection Market by Treatment (Antibiotics, Non Antibiotic Therapies), Age Group (Adults, Geriatrics, Pediatrics), Gender, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986010
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary tract infection market is undergoing steady evolution as the convergence of epidemiological shifts, technological advances, and health policy reform reshape global management strategies. Executives seeking to optimize therapeutic solutions and streamline commercial operations must navigate a landscape defined by changing disease burden, innovation in diagnostics and treatment, and complex supply chain considerations.

Market Snapshot: Urinary Tract Infection Market Overview

The urinary tract infection market grew from USD 12.47 billion in 2024 to USD 13.34 billion in 2025, with a compound annual growth rate (CAGR) of 6.96% and a forecast to reach USD 18.68 billion by 2030. These figures reflect ongoing demand driven by rising infection incidence, evolving therapy choices, and increased attention to antimicrobial resistance. Market expansion is further supported by advances in both conventional and emerging treatment modalities as well as greater healthcare infrastructure investment across diverse geographies.

Scope & Segmentation of the Urinary Tract Infection Market

  • Treatment Approaches: Includes broad-spectrum and targeted antibiotics, such as Fosfomycin, Nitrofurantoin, Trimethoprim/Sulfamethoxazole, and non-antibiotic therapies like D-Mannose, Phenazopyridine, and probiotics.
  • Patient Demographics: Covers adults, geriatrics, and pediatrics, each requiring varied dosing and management protocols.
  • Gender Considerations: Addresses unique patterns, with a notable focus on interventions tailored to females and specialized strategies for male patients.
  • Care Settings: Encompasses clinics, home care environments, and hospitals, each with distinct infrastructure and protocol requirements.
  • Regional Coverage: Analyzes trends across the Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (including United Kingdom, Germany, France, Middle East, Africa, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
  • Technology Adoption: Tracks the integration of rapid diagnostic tools, point-of-care testing, and digital health platforms into conventional management pathways.
  • Leading Companies: Profiles major players such as Pfizer Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., GlaxoSmithKline plc, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, Astellas Pharma Inc., and Bayer AG.

Key Takeaways: Strategic Insights for Decision-Makers

  • Increasing prevalence of urinary tract infections is prompting a shift toward more adaptive and preventative care models.
  • Rapid diagnostic technologies enable clinicians to make faster, more precise treatment decisions, reducing the misuse of broad-spectrum antibiotics.
  • Antibiotic resistance is spurring innovation in both pharmacological and non-pharmacological treatments, with vaccine candidates and microbiome therapies advancing in development.
  • Demographic variation in infection rates and complications highlights the importance of tailored therapeutic approaches by age, gender, and risk profile.
  • Market growth is underpinned by regional dynamics, with North America driving adoption through investment in pharmaceutical R&D, while emerging economies in the Middle East, Africa, and Asia-Pacific focus on scalable care and localized manufacturing.
  • Strategic partnerships and alliances enable organizations to accelerate time-to-market and enhance the reach of innovative therapies.

Impact of U.S. Tariff Changes on Market Dynamics

Recent shifts in United States tariff policies have impacted the cost and availability of key raw materials and pharmaceuticals, prompting manufacturers to reconsider sourcing strategies and invest in domestic production. These changes affect pricing, supply security, and competitive positioning, especially as firms diversify supplier portfolios and negotiate new contracts to mitigate volatility.

Methodology & Data Sources

This market analysis applies a multi-layered methodology, combining comprehensive secondary research from clinical publications, regulatory documents, and industry databases with primary interviews across healthcare and pharmaceutical stakeholders. Triangulation and validation processes ensure robust, accurate insights that reflect current and prospective trends in urinary tract infection management.

Why This Report Matters for Urinary Tract Infection Stakeholders

  • Offers actionable intelligence to inform product development, supply chain, and commercial strategy.
  • Supports risk management, particularly in light of policy shifts and evolving resistance patterns.
  • Enables organizations to benchmark innovation pipelines and respond proactively to regional market demands.

Conclusion

The urinary tract infection market is marked by complexity and opportunity, requiring a nuanced understanding of technology, regulation, and patient needs. Strategic insights provided here empower leaders to adapt and succeed in an evolving therapeutic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of point-of-care rapid diagnostic tests enhancing UTI management accuracy and speed
5.2. Growing preference for non-antibiotic therapies such as D-mannose and probiotics to reduce antibiotic resistance
5.3. Development of novel narrow-spectrum antibiotics targeting UTI pathogens to preserve microbiome integrity
5.4. Increasing utilization of telehealth platforms for remote diagnosis and management of urinary tract infections in primary care settings
5.5. Integration of artificial intelligence algorithms for predictive UTI recurrence risk stratification in clinical decision support systems
5.6. Expansion of antimicrobial stewardship programs within outpatient and community clinics to curb inappropriate UTI prescriptions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urinary Tract Infection Market, by Treatment
8.1. Introduction
8.2. Antibiotics
8.2.1. Fosfomycin
8.2.2. Nitrofurantoin
8.2.3. Trimethoprim/Sulfamethoxazole
8.3. Non Antibiotic Therapies
8.3.1. D Mannose
8.3.2. Phenazopyridine
8.3.3. Probiotics
9. Urinary Tract Infection Market, by Age Group
9.1. Introduction
9.2. Adults
9.3. Geriatrics
9.4. Pediatrics
10. Urinary Tract Infection Market, by Gender
10.1. Introduction
10.2. Female
10.3. Male
11. Urinary Tract Infection Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Americas Urinary Tract Infection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Urinary Tract Infection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Urinary Tract Infection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Johnson & Johnson
15.3.4. Merck & Co., Inc.
15.3.5. GlaxoSmithKline plc
15.3.6. Abbott Laboratories
15.3.7. Thermo Fisher Scientific Inc.
15.3.8. Danaher Corporation
15.3.9. Astellas Pharma Inc.
15.3.10. Bayer AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. URINARY TRACT INFECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. URINARY TRACT INFECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. URINARY TRACT INFECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. URINARY TRACT INFECTION MARKET: RESEARCHAI
FIGURE 24. URINARY TRACT INFECTION MARKET: RESEARCHSTATISTICS
FIGURE 25. URINARY TRACT INFECTION MARKET: RESEARCHCONTACTS
FIGURE 26. URINARY TRACT INFECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. URINARY TRACT INFECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FOSFOMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FOSFOMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NITROFURANTOIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NITROFURANTOIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TRIMETHOPRIM/SULFAMETHOXAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TRIMETHOPRIM/SULFAMETHOXAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY D MANNOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY D MANNOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PHENAZOPYRIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PHENAZOPYRIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 81. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 82. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 83. CANADA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 84. CANADA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 85. CANADA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 86. CANADA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 87. CANADA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 88. CANADA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 89. CANADA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 90. CANADA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 91. CANADA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 94. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 95. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 96. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 98. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 99. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 100. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 101. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 156. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 157. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 158. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 159. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 160. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 161. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 162. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 163. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 165. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 168. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 169. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 170. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 171. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 172. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 173. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 177. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 192. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 193. ITALY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 194. ITALY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 195. ITALY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 196. ITALY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 197. ITALY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. ITALY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. ITALY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 200. ITALY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 201. ITALY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ITALY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 204. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 205. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 206. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 207. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 208. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 209. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 210. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 211. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 213. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 252. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 253. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 254. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 255. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 256. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 257. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 261. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 276. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 277. QATAR URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 278. QATAR URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 279. QATAR URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 280. QATAR URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 281. QATAR URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. QATAR URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. QATAR URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 284. QATAR URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 285. QATAR URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. QATAR URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 288. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 289. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 290. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 291. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 292. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 293. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 297. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 324. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 325. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 326. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 327. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 328. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 329. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 330. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 331. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 332. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 333. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Astellas Pharma Inc.
  • Bayer AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.34 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.68 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Urinary Tract Infection Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Urinary Tract Infection Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
Urinary Tract Infection Treatment - Global Strategic Business Report - Product Image

Urinary Tract Infection Treatment - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Urinary Tract Infection Testing Market by Test Type (Automated Urinalysis, Culture Test, Molecular Test), Technology (Automated Systems, Culture Based, Immunoassays), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030 - Product Image

Urinary Tract Infection Testing Market by Test Type (Automated Urinalysis, Culture Test, Molecular Test), Technology (Automated Systems, Culture Based, Immunoassays), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Uncomplicated Urinary Tract Infection Treatment Market Report 2025 - Product Image

Uncomplicated Urinary Tract Infection Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Urinary Tract Infection Drug Market

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs. The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.